Data as of Mar 14
| -0.18 / -0.33%|
The 17 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 60.00, with a high estimate of 65.00 and a low estimate of 29.00. The median estimate represents a +11.11% increase from the last price of 54.00.
The current consensus among 22 polled investment analysts is to Buy stock in Bristol-Myers Squibb Co. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.